About Lymphoma | Advocacy | Art | CAM | Clinical trials | Doctors - Experts - Centers | Guidelines at Diagnosis | News
Risk Factors | Side Effects | Statistics | Support | Symptoms | Tests | Treatments | Types of Lymphoma

Search Site         Guidelines at Diagnosis | About Clinical Trials            How to Help!

Patients Against Lymphoma

 


Menu A to Z

 

A | B | C | D | E |
F | G | H | I | J | K
L | M | NO | P |
Q | R | S | T | U
V | W | X | Y | Z

 

Getting Started
Just Diagnosed? 
Support groups
About Lymphoma
Types of Lymphoma


A
 
Abbreviations

Acidy and cancer?

Acalabrutinib / ACP-196
(btk inhibitor) - Find trials

Adcetris - Find trials

Advisors to PAL - scientific

Advocacy perspectives

Advocacy resources

AEB071 (Sotrastaurin)  
-
Find trials

Alternative Medicine?
 
Agent Orange - compensation by VA

AGENTS targeting disease pathways

Agents, find trials by type

Alisertib - Find trials

Allogeneic Transplant

Anemia

Antibiotics for Lymphoma

Antibodies

Antibody-drug conjugates

Antibody-radiation conjugates

Animal models

Anxiety - Living Well with Lymphoma

Apoptosis - targeting

Art of Asking Questions

Arzerra - Find trials

Ask PAL a Question

Autologous Transplant

Autoimmune disease and lymphoma

Autophagy and lymphoma

 
Back to menu

 

 B

B-symptoms

Belinostat - Find trials

Beta2-microglobulin - blood marker

Bexxar

Big Picture Questions

Biomarkers

Biopsy / Second evaluation

Biopsies - perspective on mandating for research

Biospecimen Network

Bleeding / thrombocytopenia

Blood cells, types

Blood clots

Blood counts - low

Blood draw tips |
PDF

Blood tests

Blood test reference range  PDF

Bone density and  lymphoma
 

Bone marrow biopsy

Bone marrow involvement


Bone pain from growth factors

Bring to doctor list

Brochures by PAL - Decision Aids

Btk-inhibitor (ibrutinib)

Buparlisib - Find Trials

 
Back to menu

 

 

  C
 

CAM

Cancer - what is it?

CART - Engineered T-cells
Find trials

Cardiac toxicity

Careers and cancer

Caregiver help


Centers for treatment

Chemo agents by category

Chemo Brain (side effect)

Childhood lymphoma

Children - talking to about cancer

CLL

-hypogammaglobulinemia

Clinical Trials
 

- about our trial tools

- of Interest (PAL's Picks)

- find by class of agent

- find by agent - alphabetical

- find by type of lymphoma and treatment status

- focus on participation

- how to ask about

- reasons to consider trials

- reimbursement for participation?

- Trial Talk - experts to consult about trials
 

Clotting / thrombosis

CNS involvement, prophylaxis for

Compassionate Use
 

Complete Blood Count

Consent
 

Considerations at relapse

Conflict of interest in medical decisions?

Constipation, support

Conspiracy Theory?

 

Cost of medicine
 

Counterfeit drugs

Communicating our priorities to doctors

Cost of Cancer Care

CT Imaging / Risks

Curcumin?

Cutaneous lymphoma

 
Back to menu

 

 

 D

Depression is common

Diagnostic terms

DCA?

Dictionary of cancer terms NCI

Diet / Exercise

Diet as Treatment?

Diffuse Large B-Cell

DLBCL: ABC or GCB type

DLBCL: double-hit

Disparities in Health Care

Doctor, patient-recommended

Doctor, reason for second opinion

 Doctor visits: Optimize / Bring list


Doctors, art of asking questions of

Donate to help

Dose - the importance of getting it right

Double-hit lymphoma

DRUGS:

Drug costs are rising

Drug use, balancing risks and benefits - 5 questions to ask

Drug payment support

 Drugs - what is a drug?

 
Back to menu

 

 

   E

Elderly, treating

Encouragement 

Engineered T-cells

Epigenetics background

Epigenetics as basis of diet for treatment of cancer?

  Epigenetic therapy - HDAC inhibitors

Epstein Barr-Associated Lymphoma

Ethics in research

Exercise / Diet

Expanded Access to Investigational Drugs

Experts, videos

 
Back to menu

 

 

 F

 

Family history of lymphoma?

Famous people with lymphoma

Fatigue

Fertility and sex

Financial Toxicity

Find and Evaluate Online Medical info

FISH test

Flu shots?

Follicular b-cell lymphoma

Food additives

 
Back to menu

 

 

 G

 

Gazyva

GELF | NCCN
Need to Treat

 Genes and Cancer

Glossary / NCI dictionary

Goal (intent) of therapy

Grade & Stage 
 

Guestbook

Guidance to doctors

 Guidelines at Diagnosis

 
Back to menu

 

 H

Harmonizing Research and Treatment Goals

Hazard Ratio

Health Care Reform
 

Health Care Proxy

Hepatitis C and lymphoma

HIV / AIDS associated Lymphoma

Homeopathy?

Hospice

Hypogammaglobulinemia
(low levels of Ig antibody)

- IVIG - Mike's story

  

Back to menu

 

 I

 Ibrutinib

Idelalisib

Immunoglobulins

-low levels of

Immunizations


 Immune boosting as treatment?

Immune Checkpoints

Immune modulating agents

Immune suppression

Immunotherapies with links to trials

Informed consent

Insurance

Insurance correspondence log PDF

IPI | FLIPI / FLIPI-2
MIPI | CLL/SLL
 prognostic indexes

 
Back to menu

 

 J


Justice, research principle

 
Back to menu

 



 K

KLH - immune stimulant in vaccine

 

Back to menu

 

 L

LDH, blood cell marker

Lirilumab - Find Trials

Lenalidomide

Leukemic phase

Lodging

Lymphatic system


Lymphedema

Lymphoma topics

Lymphoma Awareness brochure

Lymphoma Grade

Lymphoma Simplified

Lymphoma Stage 

 

Back to menu

 

 M


Marginal Zone lymphoma | MALT | Nodal | Extranodal  Eye

MALT Support Group

Maintenance Rituxan pros and cons

Mantle Cell lymphoma (MCL)

Medical Marijuana?

MDS

Medical errors, tips to avoid

- PDF brochure
 

Medication & consult organizer PDF

Melanoma, risk of

Metastasis of Lymphoma?

Microenvironment

Mind over Body? 
Does stress cause cancer?


Minimal Residual Disease (MRD)

Mission of PAL

Monitoring lymphoma

Mouse is not a Man (or Woman)

Mouth sores | Mucositis

Myelosuppression

Myths About Cancer

 
Back to menu

 

 

 N

 Naltrexone (low dose)?

Nanotechnology

Natural supplements - caveats

Nausea

Nausea tips

NCCN practice guidelines

Need to Treat
GELF
| NCCN

Neuropathy

Night sweats

Neulasta

 
Back to menu

 

 

 O

Obinutuzumab (Gazyva)

Odds ratio

 Off-label use of cancer drugs

 Optimize visits to doctor PDF

 
Back to menu

 

 

 P

Pain

 Palliative Care

Patent law and natural compounds

Paraneoplastic Syndrome

Patient Stories

Patient-reported outcomes (PRO)

Patient Rights

Patient Tools & Decision Aids

Pathology report 

PD-1/L immune checkpoint blockade Find trials

Perspectives, advocacy

PET imaging

PI 3K kinases

PET imaging
- SUV range
- when to use

Placebo effect

Platelets, low -thrombocytopenia
 

Ports, for IV administration

Prednisone

Prognostic Factors

Programmed T-cells (CAR19)

 
Back to menu

 

 

 Q


Quackery - how it does harm 

Quality of Life

Questions for your doctor / PDF

Questions that can only be answered by clinical trials PDF


 

Back to menu

 

 R

 Radio-
immunotherapy (RIT)


Radiotherapy

Radioimmunotherapy

Rationale for continued study of Radioimmunotherapy

Red flags - identifying implausible medical claims

 Refractory 

Relative Risk

Relapse - considerations

* Report Misleading Medical Promotions

Reputable, is it?  PDF
 

Response, Remission ... Terminology

Revlimid (lenalidomide)

Research Advocacy - resources

Remission / response terms

Research Tools

Recipe for Progress

Risk factors

Risks and Benefits, balancing

  Rituxan

Rituxan checklist for patients on treatment
 

Rituxan Maintenance

- Pros and Cons of 

 

Back to menu

 

 
S


 Safety, avoiding medical errors PDF

Settings, our unique clinical circumstance

 Sex & Fertility

Shingles

Side effects

Side effect, report to FDA

Sjögren Syndrome

Skin, side effects

Skin / cutaneous lymphoma

Splenectomy

Spontaneous regression

Staging

Statistics

Stem cell Transplant

Stories by patients 

Stories - Limitations

Stress causing lymphoma?

Stress, caregiver - tips

Subcutaneous Injections

Sugar restriction?

Support Groups  

Symptoms 


Symptoms, reporting PDF

Symptoms Checklists 

 
Back to menu

 

 

   T
 

T-cell lymphomas

T-cell therapies for lymphoma Find trials

Targeted drug - terminology

Tips for dealing with R-chemo

Tests (labs, imaging)

Test results,  rules and tips


Testicular lymphoma

 Testimonials?  PDF

Tools & Tips

Transformation to aggressive lymphoma  

Transplant (stem cell)

Travel help

Treatment

Treatment decisions

Treatment decisions - Big Picture Questions


Treatment, factors that determine type & timing

Treatment goals
 

Treatment, preparing for PDF

Treatment, options at relapse

Treatment settings

Treatment support

Treatment types

Treatment, when to

Trial Talk - experts to consult about trials
 

Tumor Basics

Tumor lysis syndrome

Types of lymphoma

 
Back to menu

 

 

 U

 

 
Back to menu

 

 

  V


Vaccine, investigational

Vaccine for shingles?

Vitamins

Vitamin C?

Vitamin D

 
Back to menu

 


 

 W

 Watch & Wait?

What's Lymphoma?

What's a Drug?

When laypersons give medical advice

 
Back to menu

 

  X

 

X-rays (imaging)
 

 

Back to menu

 

 

 Y

 Yoga

 
Back to menu

 

 Z

 Zevalin (radioimmunotherapy)

 
Back to menu

 




This watercolor was done this summer while I was going through Chemo for NHL.  

~D.

Evidence-based information that empowers

Ask a Question  | Comment on PAL | See Comments

 


Patients Against Lymphoma

About PAL | Contact Us | Scientific Advisors | Partners
 

PAL since 2002 a 501(c)(3)
 non profit organization
Federal Tax ID # 51-0426732

Accomplishments

The information on Lymphomation.org is not a substitute for professional medical advice or intended to replace your relationship with a physician. For all medical concerns,  you should always consult your doctor. Patients Against Lymphoma, Copyright © 2004,  All Rights Reserved. 

We ask that you be cautious about accepting online medical information - particularly testimonials. If doing your own research, scrutinize the study methods (size, type and number of studies). Ask if it's been replicated? Does it apply to your diagnosis and circumstance? ... check with your doctor, who has training and first-hand information.

    

 

 

 

 

 


New trials since SEPTEMBER 2017

What's New  

AGENTS targeting disease pathways with links to clinical trials

Broadening Eligibility Criteria to Make Clinical Trials More Representative
Joint Recommendations of the American Society of Clinical Oncology and Friends of Cancer Research
 

Support Groups

Trial Talk:
experts to consult for second opinions
 
 

  
Getting Started

Ask PAL a Question

Guidelines at Diagnosis

Patient Stories | Support Groups

Evidenced-based topics for the developed in response to patient questions and needs

Take our confidential patient/caregiver survey

and review the results in real time

Treatment support

- Back to menu -

 


Support Groups
 
   
 Moderation Policy
 

  

Forum

The PAL Forum message board requires a one-time registration It is not searchable on the web to help to protect your privacy

Patients Against Lymphoma Lymphomation Yahoo Support Group
(email-based)

MALT Support Group
Yahoo Support Group
(email-based)

Treatment Support tips by patients 

INDOLENT LYMPHOMA TREATMENT SURVEY: to learn about the treatments
you received, were offered,
and your role in decisions

interim report
 

Back to menu

 

 About Lymphoma

  Awareness - basic facts  about lymphoma --  public education

Brochures and tools

Grade | Stage 

Simplified

Lymphatic system

Overview

Transformation

What determines the type

  Where it presents

 
Back to menu

 

 Types of Lymphoma

Hodgkins
most common type for young persons

Follicular b-cell
most common indolent type 

Diffuse Large B-Cell most common aggressive type

T-cell lymphomas

Other Types of Lymphoma

 
Back to menu

  

Commentary

  Advocacy Perspectives

  Dr. Sharman's CLL & Lymphoma Blog

Weill Cornell Blog

Brian Koffman CLL blog

Participation in clinical trials!

 
Disclaimer:  The information on Lymphomation.org is not intended to be a substitute for 
professional medical advice or to replace your relationship with a physician.
For all medical concerns,  you should always consult your doctor. 
Patients Against Lymphoma, Copyright © 2004,  All Rights Reserved.